PL2711017T3 - Środek indukujący odporność - Google Patents
Środek indukujący odpornośćInfo
- Publication number
- PL2711017T3 PL2711017T3 PL12784927T PL12784927T PL2711017T3 PL 2711017 T3 PL2711017 T3 PL 2711017T3 PL 12784927 T PL12784927 T PL 12784927T PL 12784927 T PL12784927 T PL 12784927T PL 2711017 T3 PL2711017 T3 PL 2711017T3
- Authority
- PL
- Poland
- Prior art keywords
- inducing agent
- immunity inducing
- immunity
- agent
- inducing
- Prior art date
Links
- 230000036039 immunity Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011112181 | 2011-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2711017T3 true PL2711017T3 (pl) | 2017-01-31 |
Family
ID=47177051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12784927T PL2711017T3 (pl) | 2011-05-19 | 2012-05-18 | Środek indukujący odporność |
Country Status (13)
Country | Link |
---|---|
US (2) | US20140120059A1 (pl) |
EP (1) | EP2711017B1 (pl) |
JP (1) | JP5954174B2 (pl) |
KR (1) | KR101949186B1 (pl) |
CN (1) | CN103547284B (pl) |
AU (1) | AU2012256757B2 (pl) |
BR (1) | BR112013029704A2 (pl) |
CA (1) | CA2836568C (pl) |
DK (1) | DK2711017T3 (pl) |
ES (1) | ES2595161T3 (pl) |
PL (1) | PL2711017T3 (pl) |
RU (1) | RU2614386C2 (pl) |
WO (1) | WO2012157737A1 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105296603A (zh) * | 2014-07-28 | 2016-02-03 | 广州君赫生物科技有限公司 | 一种检测男性不育症Katnal1基因突变位点的试剂盒及其PCR扩增方法 |
HUE052947T2 (hu) * | 2015-04-30 | 2021-05-28 | Toray Industries | Immunitásindukáló ágens |
MX2018001298A (es) * | 2015-08-10 | 2018-05-17 | Toray Industries | Agente inductor de inmunidad. |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US153312A (en) * | 1874-07-21 | Improvement in handcuffs | ||
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
US5698396A (en) | 1995-06-07 | 1997-12-16 | Ludwig Institute For Cancer Research | Method for identifying auto-immunoreactive substances from a subject |
EP1071943A4 (en) * | 1998-04-14 | 2005-08-10 | Univ California | TEST FOR THE DETECTION OF MICROTUBULUS DEPOLYMERIZATION INHIBITORS |
CA2402563A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
AU2001259450A1 (en) * | 2000-05-05 | 2001-11-20 | Incyte Genomics, Inc. | Cytoskeleton-associated proteins |
US7108972B2 (en) * | 2001-02-21 | 2006-09-19 | Curagen Corporation | Proteins, polynucleotides encoding them and methods of using the same |
US20040078804A1 (en) | 2001-05-03 | 2004-04-22 | Henry Yue | Cytoskeleton-associated proteins |
US7193069B2 (en) | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
JP2004008216A (ja) | 2002-03-22 | 2004-01-15 | Research Association For Biotechnology | 新規な全長cDNA |
CN1957092B (zh) * | 2004-02-23 | 2013-04-03 | 诺瓦提斯公司 | P53野生型作为使用与细胞毒剂组合的mTOR抑制剂治疗的生物标志 |
BRPI0912462B1 (pt) * | 2008-08-05 | 2022-03-22 | Toray Industries, Inc | Uso de um agente indutor de imunidade, uso de um polipeptídeo e uso de um vetor recombinante |
CN107261111B (zh) * | 2009-09-03 | 2022-02-01 | 东丽株式会社 | 免疫诱导剂 |
JP2011092100A (ja) * | 2009-10-29 | 2011-05-12 | Dna Chip Research Inc | 生理的状態変化と生理的状態に変化を与える要因の効果を評価する遺伝子マーカー、評価方法、評価システム、及びコンピュータプログラム |
-
2012
- 2012-05-18 WO PCT/JP2012/062750 patent/WO2012157737A1/ja active Application Filing
- 2012-05-18 CN CN201280024226.4A patent/CN103547284B/zh not_active Expired - Fee Related
- 2012-05-18 JP JP2012525552A patent/JP5954174B2/ja not_active Expired - Fee Related
- 2012-05-18 EP EP12784927.1A patent/EP2711017B1/en not_active Not-in-force
- 2012-05-18 ES ES12784927.1T patent/ES2595161T3/es active Active
- 2012-05-18 BR BR112013029704A patent/BR112013029704A2/pt active Search and Examination
- 2012-05-18 CA CA2836568A patent/CA2836568C/en not_active Expired - Fee Related
- 2012-05-18 KR KR1020137033212A patent/KR101949186B1/ko active IP Right Grant
- 2012-05-18 PL PL12784927T patent/PL2711017T3/pl unknown
- 2012-05-18 RU RU2013156368A patent/RU2614386C2/ru active
- 2012-05-18 US US14/118,271 patent/US20140120059A1/en not_active Abandoned
- 2012-05-18 DK DK12784927.1T patent/DK2711017T3/en active
- 2012-05-18 AU AU2012256757A patent/AU2012256757B2/en not_active Ceased
-
2015
- 2015-10-13 US US14/882,307 patent/US10463725B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20140120059A1 (en) | 2014-05-01 |
WO2012157737A1 (ja) | 2012-11-22 |
CN103547284A (zh) | 2014-01-29 |
AU2012256757A1 (en) | 2014-01-09 |
KR101949186B1 (ko) | 2019-02-18 |
JP5954174B2 (ja) | 2016-07-20 |
BR112013029704A2 (pt) | 2017-08-29 |
AU2012256757B2 (en) | 2017-06-15 |
RU2614386C2 (ru) | 2017-03-27 |
JPWO2012157737A1 (ja) | 2014-07-31 |
EP2711017A4 (en) | 2014-11-05 |
CA2836568A1 (en) | 2012-11-22 |
RU2013156368A (ru) | 2015-06-27 |
EP2711017B1 (en) | 2016-08-03 |
KR20140034224A (ko) | 2014-03-19 |
ES2595161T3 (es) | 2016-12-28 |
US10463725B2 (en) | 2019-11-05 |
EP2711017A1 (en) | 2014-03-26 |
CN103547284B (zh) | 2015-11-25 |
DK2711017T3 (en) | 2016-11-07 |
CA2836568C (en) | 2020-07-21 |
US20160030540A1 (en) | 2016-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL230280B (en) | Shield unit | |
EP2873571A4 (en) | ON-BOARD CAMERA CLEANING DEVICE | |
EP2873570A4 (en) | ON-BOARD CAMERA CLEANING DEVICE | |
EP2814472A4 (en) | DITHIOAMINE REDUCING AGENTS | |
HK1197324A1 (en) | Signaling | |
GB201109414D0 (en) | Diathermy -ionisation technique | |
ZA201403090B (en) | Tropicalizing agent | |
PL2672862T3 (pl) | Jednostka sprężysta | |
IL232425A (en) | 2- Thiopyrimidinone | |
PL3701800T3 (pl) | Zastosowanie | |
ZA201304139B (en) | Combination | |
PL2606715T3 (pl) | Kombinacja prasująco-owijająca | |
SG2014001085A (en) | 18f-saccharide-folates | |
GB201206316D0 (en) | Cleaning device | |
HUE050196T2 (hu) | Vasaláselrendezés | |
PL2711017T3 (pl) | Środek indukujący odporność | |
PL2711015T3 (pl) | Środek indukujący odporność | |
EP2787050A4 (en) | LECITHIN-Organogel formers | |
TWI562734B (en) | Sense-improving agent | |
GB201104730D0 (en) | Therabra | |
EP2764870A4 (en) | MEANS FOR IMPROVED SENSUAL ASSESSMENT | |
EP2672969A4 (en) | ASSOCIATION | |
GB2488756B (en) | Attachment devices | |
GB201119436D0 (en) | Use | |
PL2589734T3 (pl) | Zestaw montażowy |